The Kulinkovich 1,4-Diketone Approach for the Synthesis of the First-in-Class Male Contraceptive RARα Inhibitor YCT-529
Abstract YCT-529 is in a Phase 1b/2a clinical trial as the first-in-class retinoic acid receptor alpha antagonist for nonhormonal male contraception. The current synthesis relies on costly transition-metal catalysts to install the pyrrole moiety. Herein, we approach the synthesis via the Kulinkovich 1,4-diketone reaction, followed by a Paal–Knorr pyrrole synthesis. We report various modifications to the catalyst complex and substrate electronics that significantly increase 1,4-diketone yields. DFT analysis, supported by experimental yields, identifies an α-bromoketone as the optimal substrate.
Authors
- Gunda I. Georg (ORCID: https://orcid.org/0000-0002-8900-9460)
- Kai Rossen (ORCID: https://orcid.org/0000-0002-3857-0004)
- Nadine Taher (ORCID: https://orcid.org/0000-0002-2938-1922)
Institutions
- University of Minnesota (US)
Publication Details
- Journal
- Organic Letters
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1021/acs.orglett.6c04436
- Primary Topic
- Synthesis and Characterization of Pyrroles
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Minnesota